![]()
Forbes
![]()
Critics: Women's Sex Pill Approval Vote Driven By PR, Not ScienceForbesOn Thursday, June 4, an advisory committee to the U.S. Food and Drug Administration voted 18-6 to recommend that the agency approve flibanserin (fluh-BANCE-uh-rin), a non-hormonal drug acting on brain chemistry that would be the first medicine ...
Post a Comment for "Critics: Women's Sex Pill Approval Vote Driven By PR, Not Science - Forbes"